Position in CGON
as of Mar 31, 2026
· filed May 15, 2026
Position Value
$27,030,850
+$20,746,259 QoQ
Shares Held
399,392
+163.9% QoQ
Ownership
0.453%
of shares outstanding
% of Portfolio
0.05%
of 13F equity value
Holder Rank
—
not a current holder
Holding Since
Mar 2024
9 quarters on record
Voting authority
Sole 0.ToString("F0")%
Shared 100.ToString("F0")%
None 0.ToString("F0")%
Common Shares in CGON Over Time
Shares Held
Position Value (USD)
Derivatives in CGON
reported options exposure · as of Mar 31, 2026CallValue
$1,752,912
CallShares
25,900
PutValue
$0
PutShares
0
Notional value of option positions as reported on Form 13F. Calls and puts are disclosed separately and do not net against the common-share stake above.
Position in Biotechnology
Healthcare · as of Mar 31, 2026Point72 Asset Management, L.P. holds $2,393,298,297 across 187 Biotechnology names. CGON ranks #29 (1.1% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | APLS |
Apellis Pharmaceuticals, Inc.
|
4,183,918 | $168,319,021 | |
| 2 | MDGL |
Madrigal Pharmaceuticals, Inc.
|
225,510 | $118,047,719 | |
| 3 | CLDX |
Celldex Therapeutics, Inc.
|
3,229,939 | $102,453,665 | |
| 4 | RYTM |
Rhythm Pharmaceuticals, Inc.
|
846,801 | $73,646,282 | |
| 5 | AXSM |
Axsome Therapeutics, Inc.
|
424,750 | $71,791,245 | |
| 6 | ABVX |
Abivax S.A.
|
637,736 | $71,011,903 | |
| 7 | LEGN |
Legend Biotech Corp
|
3,886,017 | $70,298,047 | |
| 8 | JAZZ |
Jazz Pharmaceuticals plc
|
358,634 | $67,799,757 |
All Filings in CGON
Export CSV
10 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-03-31 | $1,752,912 | 25,900 | Call | Defined | 2026-05-15 | |
| 2026-03-31 | $27,030,850 | 399,392 | Shares | Defined | 2026-05-15 | |
| 2025-12-31 | $6,284,591 | 151,363 | Shares | Defined | 2026-02-17 | |
| 2025-09-30 | $61,362,914 | 1,523,409 | Shares | Defined | 2025-11-14 | |
| 2025-06-30 | $38,357,618 | 1,475,293 | Shares | Defined | 2025-08-14 | |
| 2025-03-31 | $40,829,091 | 1,667,174 | Shares | Defined | 2025-07-21 | |
| 2024-12-31 | $8,840,868 | 308,259 | Shares | Defined | 2025-02-14 | |
| 2024-09-30 | $28,148,956 | 746,063 | Shares | Defined | 2024-11-14 | |
| 2024-06-30 | $3,485,643 | 110,410 | Shares | Defined | 2024-09-16 | |
| 2024-03-31 | $8,175,804 | 186,237 | Shares | Defined | 2024-05-15 | |
| No filing history on record for this holder in this stock. | ||||||